Kindred Biosciences, Inc. (NASDAQ:KIN)
About the company
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|Taro Pharmaceutical Industries Ltd.||TARO||2112.04||601.00||1.26||-8.25||-42.73|
|Kindred Biosciences, Inc.||KIN||200.00||43.00||2.26||-6.49||-69.69|
|Abeona Therapeutics, Inc.||ABEO||137.97||3.00||1.32||-1.47||75.95|
|Cocrystal Pharma, Inc.||COCP||39.20||2.00||1.81||-0.58||-733.84|
|China Pharma Holdings, Inc.||CPHI||16.28||11.00||1.95||-0.80||-183.34|
|Jaguar Health, Inc.||JAGX||4.94||7.00||35.30||0.02||-594.12|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
(RTTNews) - Shares of Kindred Biosciences, Inc. (KIN), are rising more than 17% Wednesday morning after the company, which develops biologics drugs for pets, announced positive results from the ...
Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive results from a pivotal efficacy study of KIND-030, a ...
Thinking about buying stock in AxoGen Inc, Oasis Petroleum, General Electric, Kopin Corp, or Kindred Biosciences?
Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall ...
Aug 5 (Reuters) - Kindred Biosciences Inc <KIN.O>::KINDRED BIOSCIENCES ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS.Q2 EARNINGS PER SHARE $0.60.Q2 EARNINGS PER SHARE ESTIMATE $0.00 -- REFINITIV ...
SAN FRANCISCO, Aug. 5, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial ...
ScanSource, Inc. (NASDAQ: SCSC) fell 12.4% to $21.60 after the company reported worse-than-expected Q4 results. Kindred Biosciences, Inc. (NASDAQ: KIN) tumbled 12.1% to $4.36 after gaining 18% on ...
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...